snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)


0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account?
    Or continue with

    Verify your email

    We’ve sent a verification link to email@email.com
    Sign in
    Lock Icon
    Lock Icon
    Don't have an account?
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    email@email.com

    Do not forget to check your spam folder

    Didn’t get the email? or Contact us

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Drugs Discovery & Development Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector (1)

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (4)

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    433 Startups 26 In the News 32 Recently Updated
    • Total Funding
      $10.79B
      Raised
      581
      Events
    • Private Funding
      $3.67B
      Raised
      357
      Rounds
    • Public Offerings
      $5.02B
      Raised
      190
      Offerings
    • M&A
      $2.1B
      Raised
      34
      Deals
    2015
    2025
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Neurim Pharmaceuticals logo

    Neurim Pharmaceuticals

    New Chemical Entities for Insomnia and Alzheimer's Disease
    1991 B2B 11-50 Mature Undisclosed
    neurology
    degenerative-diseases
    drug-discovery
    sleep-disorders
    alzheimers-disease
    pharmaceuticals
    cns-disorders
    patients
    pharma-companies
    biopharmaceutical
    seniors
    +8
    NeuroDerm logo

    NeuroDerm

    Acquired
    Drug-device Combination Solutions for Central Nervous System Disorders
    2003 B2B 51-200 Acquired $63.5M
    pharmaceuticals
    neurology
    parkinson
    drug-design
    drug-delivery
    drug-discovery
    pharma-companies
    biopharmaceutical
    medical-devices
    patients
    biotechnology
    +9
    Neurogenesis logo

    Neurogenesis

    Neurodegenerative Disease Cell Therapy
    2018 B2B 1-10 A $6.66M
    pharmaceuticals
    cell-therapy
    amyotrophic-lateral-sclerosis-(als)
    +1
    NeuroHagana logo

    NeuroHagana

    Preventing Permanent Disabilities after Neurotrauma
    2023 B2B 1-10 Pre-Funding Undisclosed
    biotechnology
    neurology
    pharmaceuticals
    disabilities
    treatments
    +3
    Neuromagen Pharma logo

    Neuromagen Pharma

    Novel Drugs for Neurodegenerative Diseases
    2021 B2B 1-10 Seed $2.5M
    pharmaceuticals
    amyotrophic-lateral-sclerosis-(als)
    degenerative-diseases
    drug-development
    cells
    +2
    NeuroMed logo

    NeuroMed

    PRESUMED INACTIVE
    Treatment for Neurological Degenerative Diseases
    2005 B2B 1-10 Acquired $1M
    therapeutics
    cell-therapy
    degenerative-diseases
    neurology
    pharmaceuticals
    +3
    NeurOptic logo

    NeurOptic

    PRESUMED INACTIVE
    Therapy for Glaucoma
    2017 B2C 1-10 Seed Undisclosed
    pharma-companies
    glaucoma
    eye-diseases
    ophthalmology
    pharmaceuticals
    +3
    Prev 1 2 3 4 5 6 7 8 9 Next
    1 2 3 4 5 6 7 8 9
    Prev Next
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    433 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $10.79B
      Raised
      581
      Events
    • Private Funding
      $3.67B
      Raised
      357
      Rounds
    • Public Offerings
      $5.02B
      Raised
      190
      Offerings
    • M&A
      $2.1B
      Raised
      34
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Neurim Pharmaceuticals logo
    Raised
    Undisclosed
    Neurim Pharmaceuticals
    New Chemical Entities for Insomnia and Alzheimer's Disease
    Founded:1991
    Business Model:B2B
    Employees:11-50
    Funding Stage:Mature
    NeuroDerm logo
    Raised
    $63.5M
    NeuroDerm
    Acquired
    Drug-device Combination Solutions for Central Nervous System Disorders
    Founded:2003
    Business Model:B2B
    Employees:51-200
    Funding Stage:Acquired
    Neurogenesis logo
    Raised
    $6.66M
    Neurogenesis
    Neurodegenerative Disease Cell Therapy
    Founded:2018
    Business Model:B2B
    Employees:1-10
    Funding Stage:A
    NeuroHagana logo
    Raised
    Undisclosed
    NeuroHagana
    Preventing Permanent Disabilities after Neurotrauma
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Neuromagen Pharma logo
    Raised
    $2.5M
    Neuromagen Pharma
    Novel Drugs for Neurodegenerative Diseases
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    NeuroMed logo
    Raised
    $1M
    NeuroMed
    PRESUMED INACTIVE
    Treatment for Neurological Degenerative Diseases
    Founded:2005
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    NeurOptic logo
    Raised
    Undisclosed
    NeurOptic
    PRESUMED INACTIVE
    Therapy for Glaucoma
    Founded:2017
    Business Model:B2C
    Employees:1-10
    Funding Stage:Seed
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,
    Prev 1 2 3 4 5 6 7 8 9 Next
    1 2 3 4 5 6 7 8 9
    Prev Next
    title